November 18, 2026
Health news, explained with evidence
LIVE

Colorectal Cancer Rates Rise in US After Decades of Decline, Study Shows

❤️ Conditions & Care 2 min read 👁 4

Recent data published in NEJM Evidence reveals that colorectal cancer rates are climbing across nearly every age group under 70 in the United States, reversing over twenty years of falling numbers.

Colorectal Cancer Rates Rise in US After Decades of Decline, Study Shows❤️Conditions & Care

Photo: ScienceDaily Cancer

Key points

  • Colorectal cancer rates reversed over 20 years of decline, rising to 38.3 cases per 100,000 in 2023.
  • The increase affects nearly every age group under 70, driven in part by a birth cohort effect starting with those born in the 1960s.
  • While expanded screening accounts for some rises in adults aged 45 to 49, rates are also climbing in well-screened older demographics.

Following more than twenty years of steady decline, colorectal cancer incidence rates in the United States are rising again, affecting nearly every age group under the age of 70. Researchers analyzing data from the National Cancer Institute discovered that after dropping from 55.2 cases per 100,000 people in 2000 down to 36.7 in 2022, the age-adjusted incidence rate climbed back to 38.3 in 2023. The findings, published in NEJM Evidence, indicate a concerning public health shift for the disease, which remains the second leading cause of cancer deaths nationally and the primary cause among adults under 50.

Led by Caitlin Murphy, a professor of pediatrics and public health sciences at the University of Chicago, the research team tracked diagnosis patterns from 2000 through 2023. The data showed that rates are now increasing in every age cohort up through ages 65 to 69. Epidemiologists point to a birth cohort effect, suggesting that individuals born in the 1960s and later face elevated risks as they move into middle age and older adulthood.

A portion of the rise is linked to updated screening practices. Notably, among adults aged 45 to 49, incidence jumped by 12.76% annually between 2019 and 2023, a trend researchers attribute to national guidelines lowering the recommended starting age for routine screening from 50 to 45. However, increased testing does not fully explain the broader upward trajectory, as rates are also climbing among adults aged 65 to 69 where screening compliance has historically remained high at around 80%.

What to know: While earlier screening helps detect previously hidden cases, the ongoing rise in older demographics suggests that unidentified risk factors may be counteracting decades of progress against the disease.

The investigators also evaluated whether pandemic-related healthcare disruptions in 2020 and 2021 skewed the findings, but the upward trend persisted even after excluding data from those years. Scientists warn that continued increases could strain healthcare systems as more patients require treatment and long-term care. Readers should consult a healthcare provider for personalized medical advice and screening recommendations.

Source ScienceDaily Cancer — sciencedaily.com/releases/2026/11/261111005843.htm ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.